Nymox Pharmaceutical (PK) Stock Quote NYMXF - Stock Price, News, Charts, Message Board, Trades

Register to chat with like-minded investors on our interactive forums.

Get Started

Home
Investing
Stocks
USA
USOTC
Nymox Pharmaceutical Corp (PK) (NYMXF) Quote

Nymox Pharmaceutical Corp (PK) (NYMXF)

0.255

0.175

(218.75%)

Closed September 08 4:00PM

Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Current Price

0.255

Bid

0.08

Ask

0.25

Volume

40,986

0.10 Day's Range 0.2849

0.0001 52 Week Range 1.40

Market Cap

Previous Close

0.08

Open

0.2849

Last Trade

Last Trade Time

Financial Volume

$ 9,133

VWAP

0.222838

Average Volume (3m)

13,942

Shares Outstanding

93,540,140

Dividend Yield

-

PE Ratio

-2.84

Earnings Per Share (EPS)

-0.07

Revenue

-

Net Profit

-6.58M

Sector

Chemicals & Chem Preps, Nec

Industry

Chemicals & Chem Preps, Nec

Website

www.nymox.com

Headquarters

Nassau, Bhs

Founded

-

Nymox Pharmaceutical Corp (PK) is listed in the Chemicals & Chem Preps sector of the OTCMarkets with ticker NYMXF. The last closing price for Nymox Pharmaceutical (PK) was $0.08. Over the last year, Nymox Pharmaceutical (PK) shares have traded in a share price range of $ 0.0001 to $ 1.40.

Nymox Pharmaceutical (PK) currently has 93,540,140 shares outstanding. The market capitalization of Nymox Pharmaceutical (PK) is $7.48 million. Nymox Pharmaceutical (PK) has a price to earnings ratio (PE ratio) of -2.84.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.215	537.5	0.04	0.3099	0.04	19969	0.06407832	CS
4	0.205	410	0.05	0.3099	0.0003	5563	0.04899397	CS
12	0.175	218.75	0.08	1.4	0.0001	13942	0.09984692	CS
26	-0.095	-27.1428571429	0.35	1.4	0.0001	17709	0.22487743	CS
52	-0.2661	-51.065054692	0.5211	1.4	0.0001	30039	0.6595413	CS
156	0.135	112.5	0.12	1.4	0.0001	46285	0.71336331	CS
260	0.135	112.5	0.12	1.4	0.0001	46285	0.71336331	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
WNBDWinning Brands Corporation (PK)	$ 0.0001 (9,900.00%)	500k
SGYIStrategy International Insurance Group Inc (CE)	$ 0.0001 (9,900.00%)	20.1k
ERGOEntia Biosciences Inc (CE)	$ 0.0001 (9,900.00%)	100
IMTLImage Protect Inc (PK)	$ 0.0001 (9,900.00%)	14.24M
AMHGQAmergent Hospitality Group Inc (CE)	$ 0.0001 (9,900.00%)	114.1k
LBWRLabwire Inc (CE)	$ 0.000001 (-99.95%)	300k
FBECFBEC Worldwide Inc (CE)	$ 0.000001 (-99.90%)	1.51M
ERHEERHC Energy Inc (CE)	$ 0.000001 (-99.83%)	500k
GMVDFG Medical Innovations Holdings Ltd (CE)	$ 0.000001 (-99.80%)	8.11k
DVFIDiversified Oil and Gas Holdings Limited (CE)	$ 0.000001 (-99.50%)	150k
HCMCHealthier Choices Management Corporation (PK)	$ 0.0001 (100.00%)	521.25M
ASIIAccredited Solutions Inc (PK)	$ 0.0008 (-15.79%)	270.16M
CGACCode Green Apparel Corp (PK)	$ 0.0001 (0.00%)	159.49M
HMBLHUMBL Inc (PK)	$ 0.00024 (-20.00%)	158.23M
PSRUValiant Eagle Inc (PK)	$ 0.00016 (60.00%)	126.84M

Renee

Renee 1 year ago

NYMX changed to NYMXF. Delisted from the Nasdaq to the OTC:

https://otce.finra.org/otce/dailyList?viewType=Additions

Triple nickle

Triple nickle 1 year ago

Spicknspan

Spicknspan 2 years ago

A one time injectable treatment for an enlarged prostate would have a huge market. Bought a few here so I know I will keep an eye on the news.

Suds Mackenzie

Suds Mackenzie 3 years ago

NDA not coming soon?

Suds Mackenzie

Suds Mackenzie 3 years ago

NDA Coming soon?

Suds Mackenzie

Suds Mackenzie 3 years ago

Up today on NO news?

Suds Mackenzie

Suds Mackenzie 3 years ago

Delays and more delays and now more dilution. $.50 coming soon.

Suds Mackenzie

Suds Mackenzie 3 years ago

Will NYMX file NDA by 9/15/21?

lytnup

lytnup 3 years ago

Less than a month away.

Nymox Announces Date for Fexapotide Filing
NEWS RELEASE
HASBROUCK HEIGHTS, NJ (May 6, 2021) Nymox Pharmaceutical Corporation (NASDAQ: NYMX) (the “Company”) is pleased to announce that it will be filing for marketing approval of Fexapotide Triflutate for BPH before the end of the summer, on or before 15 September 2021.
CEO Dr Paul Averback said, "The Company will file on or before September 15. We hope but cannot be certain that the date may be before September. Company management will communicate updates where appropriate."

https://nymox.com/files/download/45b2b195922068b

Suds Mackenzie

Suds Mackenzie 3 years ago

2ND QUARTER RESULTS DISSAPOINTING AS USUAL. STILL NO UPDATES ON NDA.

Suds Mackenzie

Suds Mackenzie 3 years ago

NDA appication coming soon? I have my doubts.

Suds Mackenzie

Suds Mackenzie 3 years ago

Suds Mackenzie

Suds Mackenzie 3 years ago

Director - James G Robinson just picked up 38,000 shares. This was his first purchase in over a 1 1/2 years and he now owns 3,550,550 shares. He has done this many times and usually buys when it drops to around $2 or less. He is 85 years old now and God Bless he lives long enough to see this drug get FDA approval and come to market.

stillchillin

stillchillin 3 years ago

Who is buying today?? Is it GR loading up in front of good news? He has a boat load and has been holding for a while

wesley_

wesley_ 3 years ago

$2.48 picked some up

Suds Mackenzie

Suds Mackenzie 4 years ago

Good news or bad? The clock is ticking!

Suds Mackenzie

Suds Mackenzie 4 years ago

Going down down down down down!

Suds Mackenzie

Suds Mackenzie 4 years ago

ANOTHER NICE DAY!

Suds Mackenzie

Suds Mackenzie 4 years ago

BIG NEWS COMING IN Q1.

Suds Mackenzie

Suds Mackenzie 4 years ago

Suds Mackenzie

Suds Mackenzie 4 years ago

NDA - Ist quarter 2021, could it finally happen?

Suds Mackenzie

Suds Mackenzie 4 years ago

Big news coming soon?

Suds Mackenzie

Suds Mackenzie 4 years ago

The year is almost over and still no significant news!

Suds Mackenzie

Suds Mackenzie 4 years ago

What is taking so long???

Suds Mackenzie

Suds Mackenzie 4 years ago

NDA NDA NDA NDA ?

Suds Mackenzie

Suds Mackenzie 4 years ago

Even more dilution???

Suds Mackenzie

Suds Mackenzie 4 years ago

NEWS TODAY. GOOD, BAD OR SAME OLD SAME OLD.

Suds Mackenzie

Suds Mackenzie 4 years ago

More dilution - $12,000,000 stock offering.

https://ih.advfn.com/stock-market/NASDAQ/nymox-pharmaceutical-NYMX/stock-news/82880626/prospectus-filed-pursuant-to-rule-424b5-424b5

Suds Mackenzie

Suds Mackenzie 4 years ago

Starting to turn Bearish on this.

Suds Mackenzie

Suds Mackenzie 4 years ago

Will NYMX ever succeed?

Suds Mackenzie

Suds Mackenzie 4 years ago

NDA ?? I will believe it when I see it.

Suds Mackenzie

Suds Mackenzie 4 years ago

Dog and pony show continues.

Suds Mackenzie

Suds Mackenzie 4 years ago

Tick Tick Tick....

Suds Mackenzie

Suds Mackenzie 4 years ago

Hopefully good news coming soon.

Suds Mackenzie

Suds Mackenzie 4 years ago

What's the holdup?

Suds Mackenzie

Suds Mackenzie 4 years ago

$12,000,000. STOCK OFFERING.

https://ih.advfn.com/stock-market/NASDAQ/nymox-pharmaceutical-NYMX/stock-news/82306706/securities-registration-foreign-private-issuer-f-3

Suds Mackenzie

Suds Mackenzie 4 years ago

Even the Coronavirus can't keep NYMX down.

Suds Mackenzie

Suds Mackenzie 4 years ago

Hope this drops under $2, I will stock up.

Suds Mackenzie

Suds Mackenzie 5 years ago

Lots of news lately. Hoping for the NDA soon.

tayronachan

tayronachan 5 years ago

But will they have anything to offer in helping stop the new corona virus, or helping the victims?
Any of this?..........."The Company has research interests in protein markers, subcellular pathology, cell death, cell proliferation, clinical models, genetic expression, morphology, and drug screening design, assays, and development. Nymox maintains an active interest in scientific collaborations and has a lengthy history of working together with prominent researchers around the world."

zumantu

zumantu 5 years ago

Suds Mackenzie

Suds Mackenzie 5 years ago

Tick, tick, tick, tick.

Suds Mackenzie

Suds Mackenzie 5 years ago

Nymox Announces New Peer Review Article on Fexapotide Pharmaco-Ablation Experimental Studies Published in Research and Report...

yankees18

yankees18 5 years ago

Suds Mackenzie

Suds Mackenzie 5 years ago

Happy New Year for NYMX.

Suds Mackenzie

Suds Mackenzie 5 years ago

Fraud, Failure or Look for NDA in 2020

Suds Mackenzie

Suds Mackenzie 5 years ago

As at November 15, 2019, 69,968,706 common shares without par value of the Corporation were outstanding.

Suds Mackenzie

Suds Mackenzie 5 years ago

RESULTS FORTHCOMING.

Suds Mackenzie

Suds Mackenzie 5 years ago

2020 2020 2020 2020 2020 2020 2020 2020 2020 2020 2020 2020 2020 2020 2020

zumantu

zumantu 5 years ago

Did I miss the big news?

Nymox Pharmaceutical (PK)

Delayed Upgrade Clock